BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3260243)

  • 1. Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults.
    McDonnell WM; Gilsdorf JR; Kent JB; Sheagren JN
    J Clin Microbiol; 1988 Jun; 26(6):1202-6. PubMed ID: 3260243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay.
    Ward JI; Greenberg DP; Anderson PW; Burkart KS; Christenson PD; Gordon LK; Kayhty H; Kuo JS; Vella P
    J Clin Microbiol; 1988 Jan; 26(1):72-8. PubMed ID: 3257763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine.
    Walter EB; Simmons SS; Clements DA
    J Infect Dis; 1994 Oct; 170(4):1050-1. PubMed ID: 7930710
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine.
    Shackelford PG; Granoff DM; Nahm MH; Scott MG; Suarez B; Nelson SJ
    J Clin Immunol; 1985 Nov; 5(6):390-5. PubMed ID: 3878849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.
    Musher D; Goree A; Murphy T; Chapman A; Zahradnik J; Apicella M; Baughn R
    J Infect Dis; 1986 Dec; 154(6):935-43. PubMed ID: 3491165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period.
    Daum RS; Sood SK; Osterholm MT; Pramberg JC; Granoff PD; White KE; Granoff DM
    J Pediatr; 1989 May; 114(5):742-7. PubMed ID: 2785591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
    Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
    J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
    Halsey NA; Johansen TL; Bowman LC; Glode MP
    Infect Immun; 1983 Mar; 39(3):1196-200. PubMed ID: 6601621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization after invasive Haemophilus influenzae type b disease. Serologic response to a conjugate vaccine.
    Edwards KM; Decker MD; Porch CR; Palmer P; Bradley R
    Am J Dis Child; 1989 Jan; 143(1):31-3. PubMed ID: 2783356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.
    Hetherington SV
    J Immunol; 1988 Jun; 140(11):3966-70. PubMed ID: 3259602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
    Shenep JL; Munson RS; Barenkamp SJ; Granoff DM
    Infect Immun; 1983 Oct; 42(1):257-63. PubMed ID: 6604698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.